These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 17876772

  • 21. Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using 19F solid-state NMR and powder X-ray diffraction.
    Liu J, Nagapudi K, Kiang YH, Martinez E, Jona J.
    Drug Dev Ind Pharm; 2009 Aug; 35(8):969-75. PubMed ID: 19360510
    [Abstract] [Full Text] [Related]

  • 22. Quantitative determination of micronization-induced changes in the solid state of lactose.
    Della Bella A, Müller M, Soldati L, Elviri L, Bettini R.
    Int J Pharm; 2016 May 30; 505(1-2):383-93. PubMed ID: 27090154
    [Abstract] [Full Text] [Related]

  • 23. Data fusion of Fourier transform infrared spectra and powder X-ray diffraction patterns for pharmaceutical mixtures.
    Haware RV, Wright PR, Morris KR, Hamad ML.
    J Pharm Biomed Anal; 2011 Dec 15; 56(5):944-9. PubMed ID: 21873013
    [Abstract] [Full Text] [Related]

  • 24. Practical considerations in development of solid dosage forms that contain cyclodextrin.
    Miller LA, Carrier RL, Ahmed I.
    J Pharm Sci; 2007 Jul 15; 96(7):1691-707. PubMed ID: 17243148
    [Abstract] [Full Text] [Related]

  • 25. Determination of low levels of amorphous content in inhalation grade lactose by moisture sorption isotherms.
    Vollenbroek J, Hebbink GA, Ziffels S, Steckel H.
    Int J Pharm; 2010 Aug 16; 395(1-2):62-70. PubMed ID: 20493937
    [Abstract] [Full Text] [Related]

  • 26. The use of net analyte signal orthogonalization in the separation of multi-component diffraction patterns obtained from X-ray powder diffraction of intact compacts.
    Moore MD, Cogdill RP, Short SM, Hair CR, Wildfong PL.
    J Pharm Biomed Anal; 2008 Jun 09; 47(2):238-47. PubMed ID: 18294800
    [Abstract] [Full Text] [Related]

  • 27. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms.
    Tiţa B, Fuliaş A, Bandur G, Marian E, Tiţa D.
    J Pharm Biomed Anal; 2011 Sep 10; 56(2):221-7. PubMed ID: 21665404
    [Abstract] [Full Text] [Related]

  • 28. Solid dispersion of acetaminophen and poly(ethylene oxide) prepared by hot-melt mixing.
    Yang M, Wang P, Huang CY, Ku MS, Liu H, Gogos C.
    Int J Pharm; 2010 Aug 16; 395(1-2):53-61. PubMed ID: 20435110
    [Abstract] [Full Text] [Related]

  • 29. Identification of Polymorphic Forms of Active Pharmaceutical Ingredient in Low-Concentration Dry Powder Formulations by Synchrotron X-Ray Powder Diffraction.
    Egusa K, Okazaki F, Schiewe J, Werthmann U, Wolkenhauer M.
    Drugs R D; 2017 Sep 16; 17(3):413-418. PubMed ID: 28905245
    [Abstract] [Full Text] [Related]

  • 30. A high throughput platform for understanding the influence of excipients on physical and chemical stability.
    Raijada D, Cornett C, Rantanen J.
    Int J Pharm; 2013 Aug 30; 453(1):285-92. PubMed ID: 22944300
    [Abstract] [Full Text] [Related]

  • 31. Physical stability of crystal hydrates and their anhydrates in the presence of excipients.
    Salameh AK, Taylor LS.
    J Pharm Sci; 2006 Feb 30; 95(2):446-61. PubMed ID: 16380975
    [Abstract] [Full Text] [Related]

  • 32. Quantitative determination of crystallinity of alpha-lactose monohydrate by Near Infrared Spectroscopy (NIRS).
    Gombás A, Antal I, Szabó-Révész P, Marton S, Erõs I.
    Int J Pharm; 2003 Apr 30; 256(1-2):25-32. PubMed ID: 12695008
    [Abstract] [Full Text] [Related]

  • 33. Considerations about the theoretically expected crushing strength of tablets from binary powder mixtures: double layer tablets versus arithmetic additivity rule.
    Belda PM, Mielck JB.
    Eur J Pharm Biopharm; 2006 Nov 30; 64(3):343-50. PubMed ID: 16914296
    [Abstract] [Full Text] [Related]

  • 34. [X-ray diffraction quantitative analysis with polynomial-fit method for polycrystalline materials].
    Yu QZ, Song LK, Chi YL, Fan SH, Li GH.
    Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Feb 30; 24(2):248-50. PubMed ID: 15769031
    [Abstract] [Full Text] [Related]

  • 35. Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions.
    Ivanisevic I, Bates S, Chen P.
    J Pharm Sci; 2009 Sep 30; 98(9):3373-86. PubMed ID: 19283767
    [Abstract] [Full Text] [Related]

  • 36. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL, Almarsson O, Peterson ML, Remenar JF, Read MJ, Lemmo AV, Ellis S, Cima MJ, Gardner CR.
    Adv Drug Deliv Rev; 2004 Feb 23; 56(3):275-300. PubMed ID: 14962582
    [Abstract] [Full Text] [Related]

  • 37. Influence of size and density of particles on flow properties of granules.
    Czarnecki W, Szumiło M, Wasik D.
    Acta Pol Pharm; 2009 Feb 23; 66(5):553-61. PubMed ID: 19894652
    [Abstract] [Full Text] [Related]

  • 38. Entrainment of lactose inhalation powders: a study using laser diffraction.
    Watling CP, Elliott JA, Cameron RE.
    Eur J Pharm Sci; 2010 Jul 11; 40(4):352-8. PubMed ID: 20417708
    [Abstract] [Full Text] [Related]

  • 39. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.
    Zidan AS, Rahman Z, Sayeed V, Raw A, Yu L, Khan MA.
    Int J Pharm; 2012 Feb 28; 423(2):341-50. PubMed ID: 22100517
    [Abstract] [Full Text] [Related]

  • 40. Influence of ageing, grinding and preheating on the thermal behaviour of alpha-lactose monohydrate.
    Garnier S, Petit S, Mallet F, Petit MN, Lemarchand D, Coste S, Lefebvre J, Coquerel G.
    Int J Pharm; 2008 Sep 01; 361(1-2):131-40. PubMed ID: 18617338
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.